In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Harte Hanks has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqGM:HHS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2025	181	-31	-1	2	N/A
12/31/2024	185	-30	-7	-3	N/A
9/30/2024	188	-30	-7	-3	N/A
6/30/2024	187	-29	-1	2	N/A
3/31/2024	190	-1	0	3	N/A
12/31/2023	191	-2	8	10	N/A
9/30/2023	197	23	11	13	N/A
6/30/2023	204	29	20	24	N/A
3/31/2023	204	32	26	31	N/A
12/31/2022	206	35	23	29	N/A
9/30/2022	203	14	20	26	N/A
6/30/2022	199	12	7	13	N/A
3/31/2022	200	17	-1	3	N/A
12/31/2021	195	13	-5	-2	N/A
9/30/2021	190	12	-6	-2	N/A
6/30/2021	188	7	-9	-5	N/A
3/31/2021	180	-8	-12	-10	N/A
12/31/2020	177	-2	-11	-8	N/A
9/30/2020	182	-6	-11	-9	N/A
6/30/2020	186	-11	-12	-11	N/A
3/31/2020	199	-9	8	11	N/A
12/31/2019	218	-27	9	12	N/A
9/30/2019	235	-22	4	7	N/A
6/30/2019	248	-26	0	4	N/A
3/31/2019	263	-28	-19	-15	N/A
12/31/2018	285	15	N/A	-9	N/A
9/30/2018	314	-16	N/A	4	N/A
6/30/2018	345	-8	N/A	14	N/A
3/31/2018	370	-5	N/A	-27	N/A
12/31/2017	384	-42	N/A	-31	N/A
9/30/2017	394	-85	N/A	-54	N/A
6/30/2017	397	-86	N/A	-49	N/A
3/31/2017	400	-90	N/A	9	N/A
12/31/2016	404	-90	N/A	15	N/A
9/30/2016	411	-18	N/A	32	N/A
6/30/2016	423	-188	N/A	28	N/A
3/31/2016	434	-187	N/A	18	N/A
12/31/2015	444	-181	N/A	33	N/A
9/30/2015	474	-170	N/A	36	N/A
6/30/2015	499	9	N/A	41	N/A
3/31/2015	530	22	N/A	39	N/A
12/31/2014	499	14	N/A	26	N/A
9/30/2014	559	21	N/A	43	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if HHS's forecast earnings growth is above the savings rate (2.9%).

Earnings vs Market: Insufficient data to determine if HHS's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if HHS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if HHS's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if HHS's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HHS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/07/07 00:50
End of Day Share Price	2025/07/07 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Harte Hanks, Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Daniel Leben	Baird
Edward Atorino	Benchmark Company
Daniel Salmon	BMO Capital Markets Equity Research

Harte Hanks Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased by 13% to US$20.00

Consensus EPS estimates fall by 46%

Price target increased by 9.5% to US$23.00

Consensus EPS estimates increase by 14%

Price target increased to US$21.00

Price target increased to US$20.00

Recent updates

Harte Hanks, Inc. Appoints David Fisher as President

We're Hopeful That Harte Hanks (NASDAQ:HHS) Will Use Its Cash Wisely

Investors Don't See Light At End Of Harte Hanks, Inc.'s (NASDAQ:HHS) Tunnel

Harte Hanks, Inc., Annual General Meeting, May 22, 2025

Harte Hanks, Inc. Announces Executive Changes

Harte Hanks, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Harte Hanks, Inc Announces Executive Changes

Harte Hanks, Inc. Appoints Sharona Sankar-King as Chief Customer and Data Officer

Harte Hanks, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell Microcap Value Index

Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues

Harte Hanks Launches Demand Generation in a Box

CEO & Director recently bought US$50k worth of stock

First quarter 2024 earnings released: US$0.024 loss per share (vs US$0.11 loss in 1Q 2023)

Harte Hanks, Inc. to Report Q1, 2024 Results on May 09, 2024

Harte Hanks, Inc., Annual General Meeting, May 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Harte Hanks, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Harte Hanks, Inc. Appoints Luke Kenny as Sr. Director of International Sales and Client Expansion

Harte Hanks, Inc. Appoints David Fisher as Chief Transformation Officer

Harte Hanks, Inc. Appoints David Garrison as Permanent Chief Financial Officer

Less than half of directors are independent

Independent Director recently bought US$68k worth of stock

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Harte Hanks, Inc. Names Ron Lee as Senior Vice President of Inside Sales

With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case

Harte Hanks, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Harte Hanks, Inc. Appoints Kelly Waller as Senior Vice President of Sales and Marketing

Harte Hanks Announces Executive Changes

Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price

Now 23% undervalued

CEO & Director recently bought US$51k worth of stock

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Harte Hanks, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Harte Hanks Inc. Appoints Kirk Davis as Member of the Board of Directors

Harte Hanks (NASDAQ:HHS) Is Experiencing Growth In Returns On Capital

Harte Hanks, Inc. Elects Genni Combes as Board Nominee

Price target decreased by 13% to US$20.00

Consensus EPS estimates fall by 46%

Harte Hanks, Inc. (NasdaqGM:HHS) announces an Equity Buyback for 10% of its issued share capital, for $6.5 million.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 9.5% to US$23.00

Should You Investigate Harte Hanks, Inc. (NASDAQ:HHS) At US$8.83?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Does Harte Hanks (NASDAQ:HHS) Deserve A Spot On Your Watchlist?

CEO & Director recently bought US$56k worth of stock

Are Investors Undervaluing Harte Hanks, Inc. (NASDAQ:HHS) By 22%?

Consensus EPS estimates increase by 14%

Price target increased to US$21.00

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity

Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)

Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger

Investor sentiment deteriorated over the past week

Harte Hanks and FEVO announce expanding partnership

Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors

Independent Director recently sold US$1.2m worth of stock

Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M

What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?

Investor sentiment improved over the past week

Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential

Price target increased to US$20.00

Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts